Stomach Cancer Exosome-based Detection
Public ClinicalTrials.gov record NCT06342427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Early Detection of Stomach Cancer With a Liquid Biopsy Based on Exosomal Micro-RNA
Study identification
- NCT ID
- NCT06342427
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- City of Hope Medical Center
- Other
- Enrollment
- 809 participants
Conditions and interventions
Conditions
- Gastric Cancer
- Gastric Adenocarcinoma
- Gastric Cancer Stage
- Gastric Neoplasm
- Gastric Lesion
- Gastric Cancer in Situ
- Gastric Cancer Stage IV
- Gastric Cancer Stage IIIB
- Gastric Cancer Stage III
- Gastric Cancer Stage IB
- Gastric Cancer Stage IA
- Gastric Cancer, Stage 0
- Gastric Cancer Stage IIIA
- Gastric Cancer Stage II
- Gastric Cancer TNM Staging
- Gastric Cancer Metastatic to Lung
- Gastric Cancer Metastatic to Liver
- Gastric Cancer Stage I
- Gastric Cancer TNM Staging Primary Tumor (T) T2B
Interventions
- DESTINEX Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2023
- Primary completion
- Jun 14, 2024
- Completion
- Jun 14, 2024
- Last update posted
- Jul 7, 2024
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06342427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06342427 live on ClinicalTrials.gov.